Leading the Charge: Woman Behind World's Largest Dialysis Company

Helen Giza, CEO of Fresenius Medical Care, highlights the potential of new weight-loss drugs like Wegovy and Ozempic to extend the lives of chronic kidney disease patients. These drugs, known as GLP-1s, offer cardiovascular benefits that could delay the progression to end-stage renal disease. Fresenius is also launching an advanced dialysis machine in the US, which mimics natural kidney function and improves survival rates. Despite challenges like staff shortages and legal issues, Fresenius continues to innovate in dialysis and renal care globally.